Other Reports

PRICE T ROWE ASSOCIATES INC /MD/

Holdings History for VERTEX PHARMACEUTICALS INC / MA - COM (VRTX)

Symbol: VRTX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.08%	0%	$681M	1.69M	-77,310	-4.37%	$402.70	Q4 2024
9/30/2024	0.09%	-0.02%	$822M	1.77M	-443,664	-20.1%	$465.08	Q3 2024
6/30/2024	0.12%	-0.13%	$1.04B	2.21M	-2,281,748	-50.8%	$468.72	Q2 2024
3/31/2024	0.23%	-0.07%	$1.88B	4.49M	-1,393,990	-23.7%	$418.01	Q1 2024
12/31/2023	0.32%	-0.05%	$2.4B	5.89M	-962,654	-14.1%	$406.89	Q4 2023
9/30/2023	0.35%	+0%	$2.38B	6.85M	+91,308	+1.35%	$347.74	Q3 2023
6/30/2023	0.33%	+0.01%	$2.38B	6.76M	+168,568	+2.56%	$351.91	Q2 2023
3/31/2023	0.31%	+0.09%	$2.08B	6.59M	+1,892,523	+40.3%	$315.07	Q1 2023
12/31/2022	0.22%	-0.02%	$1.36B	4.7M	-460,287	-8.92%	$288.78	Q4 2022
9/30/2022	0.25%	+0.01%	$1.49B	5.16M	+195,271	+3.93%	$289.54	Q3 2022
6/30/2022	0.18%	-0.01%	$1.4B	4.96M	-342,014	-6.45%	$281.79	Q2 2022
3/31/2022	0.14%	0%	$1.38B	5.3M	-116,594	-2.15%	$260.97	Q1 2022
12/31/2021	0.11%	-0.01%	$1.19B	5.42M	-276,956	-4.86%	$219.60	Q4 2021
9/30/2021	0.1%	-0.13%	$1.03B	5.7M	-7,400,245	-56.5%	$181.39	Q3 2021
6/30/2021	0.24%	-0.06%	$2.64B	13.1M	-3,451,384	-20.9%	$201.63	Q2 2021
3/31/2021	0.36%	-0.07%	$3.56B	16.5M	-3,077,048	-15.7%	$214.89	Q1 2021
12/31/2020	0.48%	-0.02%	$4.63B	19.6M	-744,000	-3.65%	$236.04	Q4 2020
9/30/2020	0.64%	-0.03%	$5.54B	20.4M	-827,578	-3.9%	$272.12	Q3 2020
6/30/2020	0.77%	-0.02%	$6.15B	21.2M	-425,404	-1.97%	$290.31	Q2 2020
3/31/2020	0.81%	-0.11%	$5.15B	21.6M	-2,901,999	-11.8%	$237.95	Q1 2020
12/31/2019	0.7%	-0.05%	$5.37B	24.5M	-1,764,208	-6.71%	$218.95	Q4 2019
9/30/2019	0.63%	+0.03%	$4.45B	26.3M	+1,404,232	+5.64%	$169.42	Q3 2019
6/30/2019	0.64%	-0.03%	$4.56B	24.9M	-1,260,763	-4.82%	$183.38	Q2 2019
3/31/2019	0.71%	+0.01%	$4.81B	26.1M	+397,233	+1.54%	$183.95	Q1 2019
12/31/2018	0.72%	+0.02%	$4.27B	25.7M	+682,806	+2.72%	$165.71	Q4 2018
9/30/2018	0.7%	-0.02%	$4.83B	25.1M	-577,057	-2.25%	$192.74	Q3 2018
6/30/2018	0.67%	-0.05%	$4.36B	25.6M	-1,925,016	-6.98%	$169.96	Q2 2018
3/31/2018	0.71%	-0.02%	$4.49B	27.6M	-770,181	-2.72%	$162.98	Q1 2018
12/31/2017	0.69%	+0.05%	$4.25B	28.3M	+1,860,145	+7.03%	$149.86	Q4 2017
9/30/2017	0.69%	+0.05%	$4.03B	26.5M	+1,895,502	+7.71%	$152.04	Q3 2017
6/30/2017	0.57%	+0.04%	$3.17B	24.6M	+1,604,569	+6.98%	$128.87	Q2 2017
3/31/2017	0.47%	+0.02%	$2.51B	23M	+1,118,318	+5.12%	$109.35	Q1 2017
12/31/2016	0.32%	-0.02%	$1.61B	21.9M	-1,623,063	-6.91%	$73.67	Q4 2016
9/30/2016	0.41%	+0%	$2.05B	23.5M	+235,525	+1.01%	$87.21	Q3 2016
6/30/2016	0.42%	-0.03%	$2B	23.2M	-1,760,630	-7.04%	$86.02	Q2 2016
3/31/2016	0.42%	+0.1%	$1.99B	25M	+6,185,022	+32.9%	$79.49	Q1 2016
12/31/2015	0.5%	+0.1%	$2.37B	18.8M	+3,832,331	+25.6%	$125.83	Q4 2015
9/30/2015	0.35%	+0.04%	$1.56B	15M	+1,548,208	+11.5%	$104.14	Q3 2015
6/30/2015	0.34%	0%	$1.66B	13.4M	-73,956	-0.55%	$123.48	Q2 2015
3/31/2015	0.33%	+0.01%	$1.59B	13.5M	+226,285	+1.7%	$117.97	Q1 2015
12/31/2014	0.34%	-0.02%	$1.58B	13.3M	-900,159	-6.34%	$118.80	Q4 2014
9/30/2014	0.35%	+0.01%	$1.59B	14.2M	+323,978	+2.34%	$112.31	Q3 2014
6/30/2014	0.28%	+0.04%	$1.31B	13.9M	+2,041,774	+17.3%	$94.68	Q2 2014
3/31/2014	0.19%	+0.04%	$836M	11.8M	+2,465,595	+26.3%	$70.72	Q1 2014
12/31/2013	0.16%		$695M	9.36M			$74.30	Q4 2013

Previous1Next

Showing 1 to 45 of 45 entries

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.